MARS Global The Scientific Partner Trusted by Global Pharma

Specialist Clinical Research Company • Biostatistics  ·  Evidence Generation  ·  Medical Writing

The Scientific Safeguard for Global Clinical Excellence.

Precision Biostatistics. Decision-Grade Evidence. Expert Insourcing.

We protect the integrity of your clinical legacy through elite methodological rigour and a 100% Q1-quartile publication success rate.

21+Countries of Global Footprint
0.9%Document Error Margin
100%Q1 Peer-Review Success Rate
15+Years Specialised CRO Leadership
60+Peer-Reviewed Publications
$4M+Secured in Grants
All Pharma Clinical Research Health Systems Academic Publishing Government

Beyond Outsourcing: This is Expert Insourcing.

In high-stakes clinical research, a single methodological oversight can jeopardise years of development. MARS Global acts as your Scientific Safeguard. We do not operate as a traditional "outsourced" vendor. Instead, we insource PhD-level expertise directly into your internal workflow providing the safety net of rigour that allows your Medical Affairs and Research teams to focus on innovation while we secure the evidence. From protocol audits to Q1-standard manuscripts, we ensure your science is unassailable.

01

Precision Biostatistics

From protocol design through to final regulatory submission, our biostatisticians are embedded directly in your workflow. Every analysis is built to withstand the scrutiny of top-tier journals and global health authorities.

Sample Size RCT Analysis Survival Analysis Mixed Models Meta-Analysis R & SAS
Discuss Your Study →
02

Decision-Grade Evidence

Market access requires evidence that moves decision-makers. We design and deliver real-world evidence strategies, HEOR frameworks, and outcomes research built to convert data into market advantage globally.

Real-World Evidence HEOR Outcomes Research E2M Framework Market Access
Explore the E2M Framework →
03

Expert Medical Writing

Scientific accuracy is not negotiable. MARS Global produces manuscripts, regulatory submissions, and clinical study reports to Q1-journal standard because your science deserves to be read, cited, and acted on.

Manuscripts CSRs Systematic Reviews Regulatory Dossiers Q1 Journals
Start a Project →

Published in the First Quartile.

Our authority isn't claimed it is peer-reviewed. MARS Global maintains a dedicated internal research hub that secures publications in top-tier Q1 journals. We bring this same academic intensity to every client project, ensuring your data isn't just processed it's positioned for global impact.

Global Pharma & Partners Academic Alliances Capacity Building In the Press

What Our Partners Say.

"

Consistently impressed with your experience, diligence, efficiency, and ability to get things done in a perfect way.

Yasser Suliman

Engagement Manager, Primary Intelligence
IQVIA KSA

"

Always available once requested 24/7. A scientific partner who never compromises on quality, regardless of the complexity or urgency of the work.

Dr. Wael Hafez

Internal Medicine Consultant
NMC Royal Hospital Abu Dhabi

"

A rare combination of intellectual versatility, methodological rigour, and an ability to translate complex ideas into actionable insights. Anyone looking for a researcher who is proactive, skilled, and genuinely committed to advancing knowledge would be fortunate to work with this team.

Nasser Al Qhtani

Medical Lead Immunology, Medical Affairs
Healthcare Strategy and Innovation

Secure Your Scientific Legacy.

Operating at the intersection of academic rigour and real-world application, MARS Global is the trusted partner for organisations that refuse to settle for "good enough" data.

>